Eliana Barrenho
Personal Details
First Name: | Eliana |
Middle Name: | |
Last Name: | Barrenho |
Suffix: | |
RePEc Short-ID: | pba885 |
[This author has chosen not to make the email address public] | |
Affiliation
(50%) Directorate for Employment, Labour and Social Affairs (ELS)
Organisation de Coopération et de Développement Économiques (OCDE)
Paris, Francehttp://www.oecd.org/els/
RePEc:edi:eloecfr (more details at EDIRC)
(50%) Business School
Imperial College
London, United Kingdomhttp://www.imperial.ac.uk/business-school
RePEc:edi:sbimpuk (more details at EDIRC)
Research output
Jump to: Working papers ArticlesWorking papers
- Barrenho, E.; & Miraldo, M.; & Propper, C; & Rose, C.;, 2019. "Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS," Health, Econometrics and Data Group (HEDG) Working Papers 19/10, HEDG, c/o Department of Economics, University of York.
- Barrenho, E & Smith, PC & Miraldo, M, 2013. "The determinants of attrition in drug development: a duration analysis," Working Papers 12204, Imperial College, London, Imperial College Business School.
Articles
- Eliana Barrenho & Marisa Miraldo & Peter C. Smith, 2019. "Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries," Health Economics, John Wiley & Sons, Ltd., vol. 28(1), pages 123-143, January.
Citations
Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.Working papers
- Barrenho, E.; & Miraldo, M.; & Propper, C; & Rose, C.;, 2019.
"Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS,"
Health, Econometrics and Data Group (HEDG) Working Papers
19/10, HEDG, c/o Department of Economics, University of York.
Cited by:
- Áureo de Paula & Imran Rasul & Pedro CL Souza, 2023.
"Identifying network ties from panel data: Theory and an application to tax competition,"
CeMMAP working papers
21/23, Institute for Fiscal Studies.
- Áureo de Paula & Imran Rasul & Pedro CL Souza, 2019. "Identifying network ties from panel data: theory and an application to tax competition," CeMMAP working papers CWP55/19, Centre for Microdata Methods and Practice, Institute for Fiscal Studies.
- Imran Rasul & Pedro Souza & Aureo de Paula, 2023. "Identifying Network Ties from Panel Data: Theory and an application to tax competition," POID Working Papers 081, Centre for Economic Performance, LSE.
- Áureo de Paula & Imran Rasul & Pedro CL Souza, 2023. "Identifying network ties from panel data: theory and an application to tax competition," IFS Working Papers WCWP21/23, Institute for Fiscal Studies.
- Áureo de Paula & Imran Rasul & Pedro CL Souza, 2023. "Identifying network ties from panel data: theory and an application to tax competition," CeMMAP working papers 02/23, Institute for Fiscal Studies.
- de Paula, Aureo & Rasul, Imran & Souza, Pedro, 2018. "Identifying Network Ties from Panel Data: Theory and an Application to Tax Competition," CEPR Discussion Papers 12792, C.E.P.R. Discussion Papers.
- Aureo de Paula & Imran Rasul & Pedro Souza, 2019. "Identifying Network Ties from Panel Data: Theory and an Application to Tax Competition," Papers 1910.07452, arXiv.org, revised Oct 2023.
- Áureo de Paula & Imran Rasul & Pedro CL Souza, 2023.
"Identifying network ties from panel data: Theory and an application to tax competition,"
CeMMAP working papers
21/23, Institute for Fiscal Studies.
- Barrenho, E & Smith, PC & Miraldo, M, 2013.
"The determinants of attrition in drug development: a duration analysis,"
Working Papers
12204, Imperial College, London, Imperial College Business School.
Cited by:
- Linde Colen & René Belderbos & Stijn Kelchtermans & Bart Leten, 2024.
"Many are called, few are chosen: the role of science in drug development decisions,"
The Journal of Technology Transfer, Springer, vol. 49(2), pages 492-517, April.
- Linde Colen & Rene Belderbos & Stijn Kelchtermans & Bart Leten, 2022. "Many are called, few are chosen: The role of science in drug development decisions," Working Papers of Department of Management, Strategy and Innovation, Leuven 706282, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
- Michael Schlander & Karla Hernandez-Villafuerte & Chih-Yuan Cheng & Jorge Mestre-Ferrandiz & Michael Baumann, 2021. "How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment," PharmacoEconomics, Springer, vol. 39(11), pages 1243-1269, November.
- Linde Colen & René Belderbos & Stijn Kelchtermans & Bart Leten, 2024.
"Many are called, few are chosen: the role of science in drug development decisions,"
The Journal of Technology Transfer, Springer, vol. 49(2), pages 492-517, April.
Articles
- Eliana Barrenho & Marisa Miraldo & Peter C. Smith, 2019.
"Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries,"
Health Economics, John Wiley & Sons, Ltd., vol. 28(1), pages 123-143, January.
Cited by:
- Javad Moradpour & Aidan Hollis, 2020. "Patient income and health innovation," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1795-1803, December.
- Massimo FLORIO, 2020.
"Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly,"
CIRIEC Working Papers
2008, CIRIEC - Université de Liège.
- Massimo Florio & Simona Gamba, 2021. "Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 92(3), pages 387-409, September.
- Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix, 2022.
"Inequities in cancer drug development in terms of unmet medical need,"
Post-Print
halshs-03672739, HAL.
- Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix, 2022. "Inequities in cancer drug development in terms of unmet medical need," PSE-Ecole d'économie de Paris (Postprint) halshs-03672739, HAL.
- Barrenho, Eliana & Halmai, Réka & Miraldo, Marisa & Tzintzun, Iván & Raïs Ali, Setti & Toulemon, Léa & Dupont, Jean-Claude K. & Rochaix, Lise, 2022. "Inequities in cancer drug development in terms of unmet medical need," Social Science & Medicine, Elsevier, vol. 302(C).
- Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix, 2022. "Inequities in cancer drug development in terms of unmet medical need," Institut des Politiques Publiques halshs-03672739, HAL.
- Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
- Vijay Mohan & Munirul Nabin, 2023. "A note on disease burden and pharmaceutical R&D," Australian Economic Papers, Wiley Blackwell, vol. 62(4), pages 633-649, December.
- Rabbani, Maysam, 2021. "Mergers with Future Rivals Can Boost Prices, Intensify Market Concentration, and Bar Entry," MPRA Paper 112864, University Library of Munich, Germany, revised 26 Apr 2022.
- Simona Gamba & Laura Magazzini & Paolo Pertile, 2019. "R&D and market size: who benefits from orphan drug regulation?," Working Papers 09/2019, University of Verona, Department of Economics.
- Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
More information
Research fields, statistics, top rankings, if available.Statistics
Access and download statistics for all items
Co-authorship network on CollEc
NEP Fields
NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.- NEP-HEA: Health Economics (2) 2013-11-16 2019-08-12
- NEP-EUR: Microeconomic European Issues (1) 2019-08-12
- NEP-INO: Innovation (1) 2019-08-12
- NEP-SOC: Social Norms and Social Capital (1) 2019-08-12
- NEP-URE: Urban and Real Estate Economics (1) 2019-08-12
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.
To update listings or check citations waiting for approval, Eliana Barrenho should log into the RePEc Author Service.
To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.
To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.
Please note that most corrections can take a couple of weeks to filter through the various RePEc services.